World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
86
Citations
28240
World Ranking
14093
National Ranking
745

Overview

Inga Zerr is affiliated with the University of Göttingen in Germany and has an extensive research record predominantly in medicine and biochemistry, genetics, and molecular biology. Their scholarly output mainly addresses neurology and molecular biology, with additional focus on physiology, nutrition and dietetics, and psychiatry and mental health as subfields of study.

The scientist's research topics prominently include prion diseases and protein misfolding, neurological diseases and metabolism, Alzheimer's disease research and treatments, and Parkinson's disease mechanisms and treatments. Other areas of focus involve trace elements in health, neurological disorders and treatments, and autoimmune neurological disorders and treatments.

Inga Zerr's recent publications cover a range of topics within neurology and dementia-related disorders. Notable papers include:

  • Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease, 2021, The Lancet Neurology
  • The importance of ongoing international surveillance for Creutzfeldt-Jakob disease, 2021, Nature Reviews Neurology
  • Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS, 2024, Nature Medicine
  • Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia, 2020, Nature Communications
  • Rapidly progressive dementias - aetiologies, diagnosis and management, 2022, Nature Reviews Neurology

The frequent co-authors collaborating with Inga Zerr include Péter Hermann, Matthias Schmitz, Saima Zafar, Franc Llorens, and Stefan Goebel.

The primary venues for publication are diverse but with repeated contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Alzheimer's & Dementia
  • International Journal of Molecular Sciences
  • Journal of Neurology
  • Translational Neurodegeneration

Best Publications

  • Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects

    Piero Parchi;Armin Giese;Sabina Capellari;Paul Brown

  • Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

    I. Zerr;K. Kallenberg;D. M. Summers;C. Romero

  • Iatrogenic Creutzfeldt-Jakob disease at the millennium.

    P. Brown;M. Preece;J.-P. Brandel;T. Sato

  • Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.

    I. Zerr;M. Pocchiari;S. Collins;J.P. Brandel

  • Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease

    Inga Zerr;Monika Bodemer;Olaf Gefeller;Markus Otto

  • Genetic prion disease: the EUROCJD experience.

    Gábor G. Kovács;Maria Puopolo;Anna Ladogana;Maurizio Pocchiari

  • Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada

    A. Ladogana;M. Puopolo;E. A. Croes;H. Budka

  • Quantifying prion disease penetrance using large population control cohorts

    Eric Vallabh Minikel;Eric Vallabh Minikel;Sonia M. Vallabh;Sonia M. Vallabh;Monkol Lek;Monkol Lek;Karol Estrada;Karol Estrada

  • Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

    Markus Otto;Jens Wiltfang;Hayrettin Tumani;Inga Zerr

  • Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.

    S J Collins;P Sanchez-Juan;C L Masters;G M Klug

  • Accuracy and Reliability of Periodic Sharp Wave Complexes in Creutzfeldt-Jakob Disease

    Bernhard J. Steinhoff;Sabine Racker;Gregor Herrendorf;Sigrid Poser

  • Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

    Piotr Lewczuk;Peter Riederer;Sid E. O’Bryant;Marcel M. Verbeek

  • CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

    P. Sanchez-Juan;A. Green;A. Ladogana;N. Cuadrado-Corrales

  • Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.

    Peter Hermann;Brian Appleby;Brian Appleby;Jean-Philippe Brandel;Byron Caughey

  • Predictors of survival in sporadic Creutzfeldt–Jakob disease and other human transmissible spongiform encephalopathies

    M. Pocchiari;M. Puopolo;E. A. Croes;H. Budka

  • α-synuclein interacts with PrP C to induce cognitive impairment through mGluR5 and NMDAR2B

    Diana G Ferreira;Mariana Temido-Ferreira;Hugo Vicente Miranda;Hugo Vicente Miranda;Vânia L Batalha

  • Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease.

    A Alperovitch;I Zerr;M Pocchiari;E Mitrova

  • Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification

    Piero Parchi;Rosaria Strammiello;Silvio Notari;Armin Giese

  • Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease

    Bernhard J. Steinhoff;Inga Zerr;Maya Glatting;Walter Schulz-Schaeffer

  • Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease

    Andreas Schröter;Inga Zerr;Karsten Henkel;Henriette J. Tschampa

Frequent Co-Authors

Hans A. Kretzschmar
Hans A. Kretzschmar Ludwig-Maximilians-Universität München
Steven J. Collins
Steven J. Collins University of Melbourne
Jens Wiltfang
Jens Wiltfang University of Göttingen
Robert G. Will
Robert G. Will University of Edinburgh
Kaj Blennow
Kaj Blennow University of Gothenburg
Isidro Ferrer
Isidro Ferrer University of Barcelona
Gabor G. Kovacs
Gabor G. Kovacs University of Toronto
André Karch
André Karch University of Münster
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Brit Mollenhauer
Brit Mollenhauer University of Göttingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA doesn’t always mean following the traditional path to a medical degree. Many students today are turning to medical billing and coding online courses to enter the healthcare industry through administrative and technical roles. These programs are vital to supporting hospitals and clinics and can lead to rewarding careers with flexibility.

Another popular route is nursing, with a wide variety of online nursing courses now available for those seeking entry-level positions or wishing to advance their credentials. For registered nurses aiming for higher responsibility, cheapest fnp programs online provide a more affordable way to specialize as a Family Nurse Practitioner.

If you’re interested in research or teaching, pursuing the cheapest phd nursing programs can help you reach leadership roles within academia or advanced practice. Online degrees offer flexibility, affordability, and multiple entry points for diverse healthcare careers. Consider which pathway best matches your interests and long-term goals.

Best Scientists Citing Inga Zerr

Trending Scientists

Recently Published Articles